Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma

  • Xiang Chen
  • , Armita Bahrami
  • , Alberto Pappo
  • , John Easton
  • , James Dalton
  • , Erin Hedlund
  • , David Ellison
  • , Sheila Shurtleff
  • , Gang Wu
  • , Lei Wei
  • , Matthew Parker
  • , Michael Rusch
  • , Panduka Nagahawatte
  • , Jianrong Wu
  • , Shenghua Mao
  • , Kristy Boggs
  • , Heather Mulder
  • , Donald Yergeau
  • , Charles Lu
  • , Li Ding
  • Michael Edmonson, Chunxu Qu, Jianmin Wang, Yongjin Li, Fariba Navid, Najat C. Daw, Elaine R. Mardis, Richard K. Wilson, James R. Downing, Jinghui Zhang, Michael A. Dyer

Producción científica: Articlerevisión exhaustiva

645 Citas (Scopus)

Resumen

Pediatric osteosarcoma is characterized by multiple somatic chromosomal lesions, including structural variations (SVs) and copy number alterations (CNAs). To define the landscape of somatic mutations in pediatric osteosarcoma, we performed whole-genome sequencing of DNA from 20 osteosarcoma tumor samples and matched normal tissue in a discovery cohort, as well as 14 samples in a validation cohort. Single-nucleotide variations (SNVs) exhibited a pattern of localized hypermutation called kataegis in 50% of the tumors. We identified p53 pathway lesions in all tumors in the discovery cohort, nine of which were translocations in the first intron of the TP53 gene. Beyond TP53, the RB1, ATRX, and DLG2 genes showed recurrent somatic alterations in 29%-53% of the tumors. These data highlight the power of whole-genome sequencing for identifying recurrent somatic alterations in cancer genomes that may be missed using other methods.

Idioma originalEnglish
Páginas (desde-hasta)104-112
Número de páginas9
PublicaciónCell Reports
Volumen7
N.º1
DOI
EstadoPublished - oct 4 2014

Nota bibliográfica

Funding Information:
This work was supported, in part, by Cancer Center Support (CA21765) from the NCI, grants to M.A.D from the NIH (EY014867, EY018599, and CA168875), and the American Lebanese Syrian Associated Charities (ALSAC). M.A.D. is an HHMI Investigator. The whole-genome sequencing was supported as part of the St. Jude Children's Research Hospital -Washington University Pediatric Cancer Genome Project.

Financiación

This work was supported, in part, by Cancer Center Support (CA21765) from the NCI, grants to M.A.D from the NIH (EY014867, EY018599, and CA168875), and the American Lebanese Syrian Associated Charities (ALSAC). M.A.D. is an HHMI Investigator. The whole-genome sequencing was supported as part of the St. Jude Children's Research Hospital -Washington University Pediatric Cancer Genome Project.

FinanciadoresNúmero del financiador
Markey Cancer Center's Cancer Center SupportCA21765
St. Jude Children's Research Hospital -Washington University
National Institutes of Health (NIH)EY018599, CA168875
National Institutes of Health (NIH)
National Eye Institute/National Institutes of HealthR01EY014867
National Eye Institute/National Institutes of Health
National Childhood Cancer Registry – National Cancer Institute
American Lebanese Syrian Associated Charities

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • General Biochemistry, Genetics and Molecular Biology

    Huella

    Profundice en los temas de investigación de 'Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma'. En conjunto forman una huella única.

    Citar esto